The Use of CRISPR/Cas9 Technology in Engineering Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy for the Treatment of Cancer in Brazil

被引：0
|
作者：
Carvalho, Julia [1 ]
Cupello, Mauricio [2 ]
Medina, Romulo [2 ]
机构：
[1] INCA, Rio De Janeiro, Brazil
[2] Unigranrio, Rio De Janeiro, Brazil
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
CAR-T; CRISPR/Cas9; Brazil; gene editing; universal CAR-T cells;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT-312
引用
收藏
页码：S525 / S526
页数：2
相关论文
共 50 条
  • [1] Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
    Ren, Jiangtao
    Zhao, Yangbing
    PROTEIN & CELL, 2017, 8 (09) : 634 - 643
  • [2] CRISPR/Cas9 encouraged CAR-T cell immunotherapy reporting efficient and safe clinical results towards cancer
    Khan, Afreen
    Sarkar, Esha
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 33
  • [3] Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy
    Shu, Runzhe
    Hammett, Maree
    Evtimov, Vera
    Pupovac, Aleta
    Nguyen, Nhu-Y
    Islam, Rasa
    Zhuang, Junli
    Lee, Seyeong
    Kang, Tae-hun
    Lee, Kyujun
    Nisbet, Ian
    Hudson, Peter
    Lee, Jae Young
    Boyd, Richard
    Trounson, Alan
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2023, 8 (06)
  • [4] Genetical engineering for NK and T cell immunotherapy with CRISPR/Cas9 technology: Implications and challenges
    Zhi, Lingtong
    Su, Xin
    Yin, Meichen
    Zhang, Zikang
    Lu, Hui
    Niu, Zhiyuan
    Guo, Changjiang
    Zhu, Wuling
    Zhang, Xuan
    CELLULAR IMMUNOLOGY, 2021, 369
  • [5] CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
    Sasan Ghaffari
    Nastaran Khalili
    Nima Rezaei
    Journal of Experimental & Clinical Cancer Research, 40
  • [6] Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology
    Tao, Ruiyu
    Han, Xiaopeng
    Bai, Xue
    Yu, Jianping
    Ma, Youwei
    Chen, Weikai
    Zhang, Dawei
    Li, Zhengkai
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [7] CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment
    Mollanoori, Hasan
    Shahraki, Hojat
    Rahmati, Yazdan
    Teimourian, Shahram
    HUMAN IMMUNOLOGY, 2018, 79 (12) : 876 - 882
  • [8] Optimizing cancer treatment: the synergistic potential of CAR-T cell therapy and CRISPR/Cas9
    Amiri, Maryam
    Moaveni, Amir Kian
    Zolbin, Masoumeh Majidi
    Shademan, Behrouz
    Nourazarian, Alireza
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [9] CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
    Ghaffari, Sasan
    Khalili, Nastaran
    Rezaei, Nima
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [10] Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies
    Maganti, Harinad B.
    Kirkham, Aidan M.
    Bailey, Adrian J. M.
    Shorr, Risa
    Kekre, Natasha
    Pineault, Nicolas
    Allan, David S.
    CYTOTHERAPY, 2022, 24 (04) : 405 - 412
12345